Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemia

about

Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemia

Item

http://www.wikidata.org/entity/Q41981064

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Role of peripheral blood minim ...... ith acute lymphocytic leukemia

@en

type

Item

label

Role of peripheral blood minim ...... ith acute lymphocytic leukemia

@en

prefLabel

Role of peripheral blood minim ...... ith acute lymphocytic leukemia

@en

P1476

Role of peripheral blood minim ...... ith acute lymphocytic leukemia

@en

P2093

Cristina Motta Ferreira

http://www.w3.org/2001/XMLSchema#string

Eliana Brasil Alves

http://www.w3.org/2001/XMLSchema#string

Erich Vinícius De Paula

http://www.w3.org/2001/XMLSchema#string

Leny da Mota Passos

http://www.w3.org/2001/XMLSchema#string

Thais Ditolvo da Costa Salina

http://www.w3.org/2001/XMLSchema#string

Yvelise Antunes Ferreira

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.

New markers for minimal residual disease detection in acute lymphoblastic leukemia.

Treatment of pediatric acute lymphoblastic leukemia.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.

P2888

srep31179

P304

31179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP31179

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcelo Mira

P577

2016-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038607987

http://www.w3.org/2001/XMLSchema#string

P698

27526794

http://www.w3.org/2001/XMLSchema#string

P932

4985643

http://www.w3.org/2001/XMLSchema#string